Pricing
  1. JP-listed companies
  2. COSMO BIO COMPANY, LIMITED
  3. Financials
  4. Return on equity (%)

COSMO BIO COMPANY, LIMITED【JP:3386】

Market cap
¥7.9B
P/E ratio
33.8x
Cosmo Bio imports and sells life science research reagents and equipment to researchers at universities and corporations, offering over 10 million products from 500 companies worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on equity (%) (Million JPY)YoY (%)
Dec 31, 20253.5+18.97%
Dec 31, 20242.9-44.55%
Dec 31, 20235.2-19.79%
Dec 31, 20226.5-31.30%
Dec 31, 20219.5+2.82%
Dec 31, 20209.2+169.88%
Dec 31, 20193.4-14.50%
Dec 31, 20184+7.24%
Dec 31, 20173.7-12.44%
Dec 31, 20164.3+19.66%
Dec 31, 20153.6+17.88%
Dec 31, 20143

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)